| 1 |
Jung, B.-J., Yoo, H.-S., Shin, S., Park, H.-J. and Jeon, S.-M. (2018) Dysregulation of NRF2 in cancer: from molecular mechanisms to therapeutic opportunities. Biomol. Ther. (Seoul) 26, 57-68./
|
|
| 2 |
Min, H.-Y. and Lee, H.-Y. (2018) Oncogene-driven metabolic alterations in cancer. Biomol. Ther. (Seoul) 26, 45-56./
|
|
| 3 |
Momcilovic, M. and Shackelford, D. B. (2018) Imaging cancer metabolism. Biomol. Ther. (Seoul) 26, 81-92./
|
|
| 4 |
Neugent, M. L., Goodwin, J., Sankaranarayanan, I., Yetkin, C. E., Hsieh, M. H. and Kim, J.-w. (2018) A new perspective on the heterogeneity of cancer glycolysis. Biomol. Ther. (Seoul) 26, 10-18./
|
|
| 5 |
Kim, J.-A. and Yeom, Y. I. (2018) Metabolic signaling to epigenetic alterations in cancer. Biomol. Ther. (Seoul) 26, 69-80./
|
|
| 6 |
Kim, S.-Y. (2018) Cancer energy metabolism: shutting power off cancer factory. Biomol. Ther. (Seoul) 26, 39-44./
|
|
| 7 |
Dang, C. V. and Kim, J.-w. (2018) Convergence of cancer metabolism and immunity: an overview. Biomol. Ther. (Seoul) 26, 4-9./
|
|
| 8 |
Cho, E. S., Cha, Y. H., Kim, H. S., Kim, N. H. and Yook, J. I. (2018) The pentose phosphate pathway as a potential target for cancer therapy. Biomol. Ther. (Seoul) 26, 29-38./
|
|
| 9 |
Choi, Y.-K. and Park, K.-G. (2018) Targeting glutamine metabolism for cancer treatment. Biomol. Ther. (Seoul) 26, 19-28./
|
|
| 10 |
Oh, H. J., Magar, T. B. T., Pun, N. T., Lee, Y., Kim, E. H., Lee, E. S. and Park, P. H. (2018) YJI-7 suppresses ROS production and expression of inflammatory mediators via modulation of p38MAPK and JNK signaling in RAW 264.7 macrophages. Biomol. Ther. (Seoul) 26, 191-200./
|
|